In a major milestone for Australian cancer patients, the not-for-profit, member-based organisation, Cancer Trials Australia (CTA), has recently marked the recruitment of the 10,000th oncology patient to clinical trials [...]
Isolation is tough, especially when your workplace is a great place to be - the lack of incidental chatter and the enjoyment that comes from interacting with our workmates [...]
I am pleased to share with you the 2019 Cancer Trials Australia Annual Report. Download the 2019 Annual Report Here. The 2019 calendar year saw continued growth in both [...]
Cancer Trials Australia (CTA) is pleased to announce that a Phase 1 Oncology Clinical Trials Fellowship Program will be piloted in Victoria throughout 2020 and 2021 in partnership with [...]
Cancer Trials Australia’s CEO, Dr. Kurt Lackovic, was a panelist at the 12th annual ‘China Trials – Clinical Development Leaders’ summit’ in Shanghai this week. Other panelists included Jayden [...]
Cancer Trials Australia (CTA) is pleased to announce a new project, to be delivered with the Victorian Comprehensive Cancer Centre (VCCC), providing Victorian sites with an exciting opportunity to [...]
Working closely with Marian Lieschke, Heike Raunow and Kylie Shackleton, CTA’s 2019 Research Manager’s Day was held on 17 October. 18 participants joined this highly productive forum from across [...]
By 2021, the global market for clinical trials is anticipated to grow to $60Bn, a 75% increase over 2015. The largest contributor to this huge growth is the Asia-Pacific region.Cancer [...]
CTA has experienced significant growth over recent years, which has accelerated throughout 2019. Dedicating time to team development activities not only helps to integrate new staff into the wider [...]
I am pleased to share with you the 2018 Cancer Trials Australia Annual Report. Download the 2018 Annual Report Here. The 2018 calendar year saw growth in both CTA [...]
Invest Victoria recently profiled the strength of interactions between Cancer Trials Australia and BeiGene, a rapidly growing Chinese biopharmaceutical company, with over 1,700 staff across four continents and more than [...]
CTA has executed an MOU with ShareRoot Limited (ASX: SRO) to explore the application of ShareRoot’s MediaConsent platform as a tool to improve the dynamics of clinical trial recruitment, patient [...]
CTA announces partnership in delivering coordinated Electronic Document Management for Victorian study sites Cancer Trials Australia (CTA) is pleased to announce a new project funded by the Victorian Comprehensive [...]
Due to an improved partnership between South West Healthcare (SWH) and CTA, cancer patients will have greater access to potentially life-saving therapies they may not have otherwise had access to. SWH medical oncologist Ian [...]
Cancer Trials Australia is pleased to announce the addition of our 26th major healthcare provider member, Calvary Central Districts Hospital, located in South Australia. This partnership builds on Calvary's [...]
Cancer Trials Australia (CTA) is pleased to announce execution of a Services Agreement with the VCCC to provide Site Management Services for the VCCC’s Investigator Initiated Trial Program. Professor [...]
I am pleased to share the 2017 Cancer Trials Australia Annual Report. Download the 2017 Annual Report Here. 2017 saw expansion of CTA membership and significant growth in CTA services for [...]
Cancer Trials Australia celebrates their support of 1,000 commercially sponsored clinical trials and the recruitment of 8,000 patients, in conjunction with International Clinical Trials Day on May 21st, 2018 Since [...]
Cancer Trials Australia's CEO, Dr Kurt Lackovic, was recently invited to speak at an international webinar showcasing Melbourne as a premier location for the conduct of Phase 1 clinical trials. Aimed primarily at international [...]
More patients will have access to potentially life-saving cancer therapies as a result of Epworth joining forces with Cancer Trials Australia. With the addition of Epworth, CTA now has [...]
I am pleased to share the Cancer Trials Australia 2016 Annual Report. Download the 2016 Annual Report Here. 2016 saw growth in CTA membership and corresponding CTA service activity. CTA welcomed [...]
Cancer Trials Australia (CTA) is pleased to announce that Linear Clinical Research has signed a Members Agreement to join the CTA Member Network The CTA network now includes 24 [...]
Cancer Trials Australia (CTA) is proud to be part of the successful Cancer Council Victoria (CCV) grant application for the establishment of a cancer clinical trials network across seven [...]
Chairman of the Board, Professor Andrew Scott, with great pleasure advised that the next Chief Executive Officer of Cancer Trials Australia (CTA) will be Dr Kurt Lackovic. Professor Scott said [...]
Cancer Trials Australia (CTA) announced today that the Shepparton Hospital, through Goulburn Valley Health, and Northern Adelaide Cancer Centre Clinical Trials Unit, operating as the Lyell McEwin Hospital, have [...]
